Robert B. Bazemore, President & CEO at Epizyme, Inc. (EPZM), sold 10,000 shares at $22.00 ($220K) on 2020-06-18, disclosed to the SEC on 2020-06-22.
Open-market sale of $220k EPZM by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| EPZM | SELL | 2021-02-05 | $44K | — | Filing → |
| EPZM | SELL | 2021-01-27 | $138K | — | Filing → |
| EPZM | SELL | 2020-06-30 | $154K | — | Filing → |